About Bioskryb
Bioskryb is a company based in Durham (United States) founded in 2018 by Jay West and Charles Gawad. Bioskryb has raised $11.5 million across 1 funding round from investors including Wilson Sonsini Goodrich & Rosati and Anzu Partners. The company has 21 employees as of December 31, 2021. Bioskryb offers products and services including ResolveOME, BaseJumper, and ResolveDNA. Bioskryb operates in a competitive market with competitors including Nanopore, PacBio, Omniome, Complete Genomics and QuantuMDx, among others.
- Headquarter Durham, United States
- Employees 21 as on 31 Dec, 2021
- Founders Jay West, Charles Gawad
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Bioskryb Genomics, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$11.5 M (USD)
in 1 rounds
-
Latest Funding Round
$11.5 M (USD), Seed
Jan 09, 2020
-
Investors
Wilson Sonsini Goodrich & Rosati
& 1 more
-
Employee Count
21
as on Dec 31, 2021
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Bioskryb
Bioskryb offers a comprehensive portfolio of products and services, including ResolveOME, BaseJumper, and ResolveDNA.
Amplifies genome and transcriptome from single cells for integrated analysis.
Visualizes single-cell genomics data for molecular discovery insights.
Enables high genome recovery and variant detection in single-cell research.
People of Bioskryb
Unlock access to complete
Unlock access to complete
Funding Insights of Bioskryb
Bioskryb has successfully raised a total of $11.5M through 1 strategic funding round. The most recent funding activity was a Seed round of $11.5 million completed in January 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Seed — $11.5M
-
First Round
First Round
(09 Jan 2020)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2020 | Amount | Seed - Bioskryb | Valuation | Anzu Partners |
Investors in Bioskryb
Bioskryb has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include Wilson Sonsini Goodrich & Rosati and Anzu Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investments are made in industrial and life sciences technology companies.
|
Founded Year | Domain | Location | |
|
Provider of legal services to technology and life science companies
|
Founded Year | Domain | Location |
Investments & Acquisitions by Bioskryb
Financial Statements - Bioskryb
Bioskryb Comparisons
Competitors of Bioskryb
Bioskryb operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Nanopore, PacBio, Omniome, Complete Genomics and QuantuMDx, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Nanopore-based electronic systems for single-molecule analysis are developed.
|
|
| domain | founded_year | HQ Location |
Instrument systems and software for single-molecule real-time sequencing are developed.
|
|
| domain | founded_year | HQ Location |
Genome sequencing platform is provided for clinical diagnostics.
|
|
| domain | founded_year | HQ Location |
DNA sequencing platform for human genome analysis is developed.
|
|
| domain | founded_year | HQ Location |
Handheld diagnostic and sequencing devices are developed for personalized healthcare.
|
|
| domain | founded_year | HQ Location |
Provider of genome analysis solutions to researchers and clinicians
|
Latest news on Bioskryb
Frequently Asked Questions about Bioskryb
Bioskryb was founded in 2018 and raised its 1st funding round 2 years after it was founded.
Bioskryb is headquartered in Durham, United States. It is registered at Durham, North Carolina, United States.
Jay West is the current CEO of Bioskryb. They have also founded this company.
Bioskryb is a funded company, having raised a total of $11.5M across 1 funding round to date. The company's 1st funding round was a Seed of $11.5M, raised on Jan 09, 2020.
As of Dec 31, 2021, the latest employee count at Bioskryb is 21.
BioSkryb has developed a genome amplification system for cellular heterogeneity. The SkrybAmp technology performs Primary Template Directed Amplification (PTA) is used for base calling DNA sequencing. The features of the technology are it can control the amplicon size for adding Barcode identifiers to detect DNA lesions. The technology is applied in ancestry genotyping, gene editing accuracy determination, and detection of single resistant mutant cells (MRD) in cancers.
Bioskryb offers ResolveOME, BaseJumper, and ResolveDNA.
Bioskryb has 2 investors. Key investors include Wilson Sonsini Goodrich & Rosati, and Anzu Partners.